Back to Results
First PageMeta Content
Growth hormones / Biology / Growth hormone treatment / Growth hormone deficiency / Methadone / Growth hormone / Birth weight / SDS-PAGE / Medicine / Chemistry / Pediatrics


Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Humatrope
Add to Reading List

Document Date: 2012-06-04 08:47:11

Open Document

File Size: 477,22 KB

Share Result on Facebook

City

Cologne / Methods / /

Company

FHD Group (N=89) IAD Group / First Year (N=169) FHD Group (N=89) IAD Group / AEs / IAD Group Group / FHD Group Group / Lilly Deutschland GmbH / FHD Group (N=99) IAD Group / Patients [95% CI for Percentage] FHD Group (N=99) IAD Group / H01AC01 Pharmaceutical / Indication(s) Lilly Deutschland GmbH / /

Event

Product Issues / FDA Phase / /

Facility

Humatrope INN / /

IndustryTerm

treatment of children who have growth failure / treatment of patients who have growth failure / medicinal product / pharmaceutical / /

MedicalCondition

Turner Syndrome / tumor / insulin resistance / epiphysiolysis / disease / arthralgia / headache / nasopharyngitis / hypothyroidism / bronchitis / hyperglycemia / chronic / chronic renal insufficiency / hormone deficiency / focal glomerulosclerosis / Prader-Willi syndrome / vomiting / benign intracranial hypertension / obesity / diseases / SHOX deficiency / hirsutism / tonsillitis / deficiency / hypoglycemia / scoliosis / Syndrome / /

MedicalTreatment

cranial irradiation / /

Person

Short Children / /

Position

investigator / Major / /

Product

Humatrope / secretion / B9RHL-GDGN / /

ProvinceOrState

South Dakota / /

SocialTag